Rønnov-Jessen L, Petersen O W
Structural Cell Biology Unit, Panum Institute, University of Copenhagen, Denmark.
Lab Invest. 1993 Jun;68(6):696-707.
By using a novel experimental system for the study of reactive fibroblast differentiation at the molecular level, we describe the induction of the alpha-isoform of smooth muscle actin by transforming growth factor-beta (TGF-beta 1) in human normal breast gland fibroblasts.
The experimental system allowed fibroblasts to plate and remain quiescent and nonreactive but at the same time stay sensitive to environmental cues for more than 2 weeks after explantation. Most important, the biological activity of growth factors and cytokines could be studied without cells entering the cell cycle, thus serving as a model for stromal reactions with little cell turnover.
By use of double-labeling immunocytochemistry, isoelectric focusing, two-dimensional gel electrophoresis, and fluorography, evidence is presented that the effect of TGF-beta 1 is dose-dependent with a maximal response above 80 pg/ml and a course of 6 days. No other growth factor/cytokine tested (platelet-derived growth factor, interleukin-1, insulin-like growth factor-1, acidic fibroblast growth factor, basic fibroblast growth factor, epidermal growth factor, and interferon-gamma) could induce alpha-smooth muscle actin on their own or potentiate the effect of TGF-beta 1. In an inhibitory assay, only basic fibroblast growth factor was found to prevent the action of TGF-beta 1. The relative contribution of TGF-beta 1-like activity to carcinoma cell induced alpha-smooth muscle actin in fibroblasts was deciphered using TGF-beta neutralizing antibodies and medium conditioned by two different breast carcinoma cell lines. Conditioned medium elicited a fibroblast response indistinguishable from that obtained with exogenously added TGF-beta 1, and indeed neutralization attributed the entire response to the sole effect of secreted TGF-beta 1-like activity.
These results provide a strategy for the molecular characterization of epithelial-stromal interaction in breast neoplasia.
通过使用一种用于在分子水平研究反应性成纤维细胞分化的新型实验系统,我们描述了转化生长因子-β(TGF-β1)在人正常乳腺成纤维细胞中诱导平滑肌肌动蛋白α异构体的过程。
该实验系统使成纤维细胞能够接种并保持静止和无反应状态,但同时在植入后2周多的时间内对环境信号保持敏感。最重要的是,可以在细胞不进入细胞周期的情况下研究生长因子和细胞因子的生物活性,从而作为细胞更新很少的基质反应模型。
通过使用双标记免疫细胞化学、等电聚焦、二维凝胶电泳和荧光自显影,有证据表明TGF-β1的作用是剂量依赖性的,在80 pg/ml以上有最大反应,过程为6天。所测试的其他生长因子/细胞因子(血小板衍生生长因子、白细胞介素-1、胰岛素样生长因子-1、酸性成纤维细胞生长因子、碱性成纤维细胞生长因子、表皮生长因子和干扰素-γ)自身均不能诱导α平滑肌肌动蛋白,也不能增强TGF-β1的作用。在抑制试验中,仅发现碱性成纤维细胞生长因子可阻止TGF-β1的作用。使用TGF-β中和抗体和两种不同乳腺癌细胞系条件培养基,解读了TGF-β1样活性对癌细胞诱导成纤维细胞中α平滑肌肌动蛋白的相对贡献。条件培养基引起的成纤维细胞反应与外源性添加TGF-β1所获得的反应无法区分,实际上中和作用将整个反应归因于分泌的TGF-β1样活性的唯一作用。
这些结果为乳腺肿瘤上皮-基质相互作用的分子特征研究提供了一种策略。